These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 175026)

  • 21. Interactions between Epstein-Barr virus (EBV) and human cell lines: growth and EBV induction.
    Takimoto T; Iwawaki J; Tanaka S; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(1):40-6. PubMed ID: 2154734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.
    Clements GB; Klein G; Povey S
    Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    Knutson JC
    J Virol; 1990 Jun; 64(6):2530-6. PubMed ID: 2159528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
    Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
    Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
    Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
    Leinbach SS; Summers WC
    J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis.
    Sculley TB; Walker PJ; Moss DJ; Pope JH
    J Virol; 1984 Oct; 52(1):88-93. PubMed ID: 6090712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
    Mueller-Lantzsch N; Yamamoto N
    J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of Epstein-Barr virus-determined nuclear antigen (EBNA) by chromatography on fixed cell nuclei.
    Hirsch I; Suchánková A; Závadová H; Vonka V
    Int J Cancer; 1978 Nov; 22(5):535-41. PubMed ID: 82540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of an Epstein-Barr virus (EBV) genome-positive subline of Ramos (Ramos/NPC) following infection of Ramos with nasopharyngeal carcinoma (NPC)-derived EBV.
    Takimoto T; Sato H; Ogura H; Miyazaki T
    Auris Nasus Larynx; 1987; 14(2):87-92. PubMed ID: 2835030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induced CD25 expression in a human B-lymphoma cell line transfected with the Epstein-Barr virus nuclear antigen 2 gene.
    Harada S; Yanagi K
    Microbiol Immunol; 1992; 36(5):479-94. PubMed ID: 1325025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
    Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
    Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appearance of Epstein-Barr virus nuclear antigen in human cordblood lymphocytes.
    Wright J; Falk L; Deinhardt F
    IARC Sci Publ (1971); 1975; (11 Pt 1):409-14. PubMed ID: 190146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
    Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
    Fresen KO; Cho MS; zur Hausen H
    Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking of acid-fixed nuclear binding of Epstein-Barr virus nuclear antigen (EBNA) by different DNA species.
    Hirsch I; Kuchlerová L; Brichácek B; Suchánková A; Vonka V
    J Gen Virol; 1979 Sep; 44(3):849-52. PubMed ID: 231093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ.
    Moar MH; Klein G
    Int J Cancer; 1979 Nov; 24(5):679-87. PubMed ID: 93584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.
    Henle W; Henle G; Andersson J; Ernberg I; Klein G; Horwitz CA; Marklund G; Rymo L; Wellinder C; Straus SE
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):570-4. PubMed ID: 3025881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.